RCT Of Omega-3 Fatty Acids As Treatment Of Subthreshold Symptoms In Young People At Ultra-high Risk For
Funder
National Health and Medical Research Council
Funding Amount
$280,102.00
Summary
Omega-3 fats are a type of polyunsaturated fat which has long been thought to be beneficial for health. The body cannot make its own omega-3 fats - they must be taken in through the diet, or in supplement form. Large population-based studies have suggested that a diet rich in omega-3 fats can reduce the risk of cardiovascular disease, lower blood pressure, cut the risk of cancers such as prostate and skin. The fats have also been touted as a treatment for arthritis, asthma, and inflamed bowels. ....Omega-3 fats are a type of polyunsaturated fat which has long been thought to be beneficial for health. The body cannot make its own omega-3 fats - they must be taken in through the diet, or in supplement form. Large population-based studies have suggested that a diet rich in omega-3 fats can reduce the risk of cardiovascular disease, lower blood pressure, cut the risk of cancers such as prostate and skin. The fats have also been touted as a treatment for arthritis, asthma, and inflamed bowels. A lack of omega-3s during foetal development can hinder brain and eye development. Other work has suggested that a diet rich in omega-3 may help improve mental health. Studies revealed beneficial effects in a broad range of mental health problems including violent and aggressive behaviour in teenagers, major depression, bipolar affective disorder, borderline personality disorder, and schizophrenia. Evidence that omega-3 fatty acids may reduce symptoms in schizophrenia and other major psychiatric disorders make omega-3 fatty acids an optimal candidate for further evaluation of its therapeutic efficacy, in particular in young people in early illness stages of psychosis where specific intervention is controversial due to potential risks and medication side-effects. The proposed 12-week intervention study aims to establish a new treatment strategy alternative to antipsychotic medication in the young people with subthreshold symptoms at high risk for psychosis. Omega-3 fatty acids have no clinically relevant side effects which often accompany therapy with antipsychotics (such as diabetes and weight gain). A widely available, easy applicable, biological treatment without clinically relevant side effects could help to improve compliance and outcome in psychosis. Schizophrenia is often prolonged and results in a considerable economic burden. Early treatment has the potential to offset future costs to both mental health providers and the recipients of these services.Read moreRead less
A Randomised Controlled Clinical Trial Of The Effects Of EPA-rich Fish Oil In Chronic Work Stress
Funder
National Health and Medical Research Council
Funding Amount
$139,328.00
Summary
Chronic work stress doubles the risk of cardiovascular disease and depression and accounts for almost 30% of all Workers Compensation costs paid by the Australian Government. Our preliminary studies have shown (1) an inverse correlation between fish consumption and work stress, and (2) a pilot randomised controlled double-blind study demonstrated that fish oil had twice the rate of stress reduction than placebo. This study aims to show that fish oil ameliorates stress in a larger population.
Testing The Effect Of Long-chain Omega-3 Polyunsaturated Fatty Acids On Cognitive Ageing In The Elderly
Funder
National Health and Medical Research Council
Funding Amount
$738,908.00
Summary
The ageing profile of our population holds challenges for society, with some of the major impact due to loss of independence and quality of life in older people, arising from decline in cognitive functioning. Evidence suggests a benefit of Omega-3 fatty acids on cognitive functioning in older people but claims that Omega-3 slows cognitive decline have not been adequately tested. This study tests the effect of Omega-3 supplementation on cognition in healthy older people, over an 18-month period.